SIOC English
有机化学
高级检索

有机化学 >

2013 , Vol. 33 >Issue 07: 1573 - 1577

DOI: https://doi.org/10.6023/cjoc201302006

研究简报

(2S,3aR,7aS)-八氢-1H-吲哚-2-甲酸苄酯的合成

  • 时涛 ,
  • 申杰峰 ,
  • 安前进 ,
  • 刘德龙 ,
  • 刘燕刚 ,
  • 张万斌
展开
  • a 上海交通大学药学院 上海 200240;
    b 上海交通大学化学化工学院 上海 200240

收稿日期: 2013-02-02

  修回日期: 2013-02-21

  网络出版日期: 2013-02-22

基金资助

国家自然科学基金(Nos. 21172143, 21172145, 21232004)资助项目.

收起

Synthesis of (2S,3aR,7aS)-Benzyl Octahydro-1H-indole-2-carboxylate

  • Shi Tao ,
  • Shen Jiefeng ,
  • An Qianjin ,
  • Liu Delong ,
  • Liu Yangang ,
  • Zhang Wanbin
Expand
  • a School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240;
    b School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240

Received date: 2013-02-02

  Revised date: 2013-02-21

  Online published: 2013-02-22

Supported by

Project supported by the National Natural Science Foundation of China (Nos. 21172143, 21172145, 21232004).

Fold

摘要

通过合成路线的改进以及合成工艺的优化, 方便高效地得到了抗高血压药物群多普利的关键中间体 (2S,3aR,7aS)-八氢-1H-吲哚-2-甲酸苄酯. 产品结构及绝对构型通过NMR及HPLC进行表征, 与文献报道的数据完全一致. 最终以99%的对映选择性及13.2%的产率得到目标化合物. 为群多普利关键中间体的合成提供了一条可工业化的途径.

关键词： 群多普利; 八氢-1H-吲哚-2-甲酸苄酯; 合成

本文引用格式

时涛 , 申杰峰 , 安前进 , 刘德龙 , 刘燕刚 , 张万斌 . (2S,3aR,7aS)-八氢-1H-吲哚-2-甲酸苄酯的合成[J]. 有机化学, 2013 , 33(07) : 1573 -1577 . DOI: 10.6023/cjoc201302006

Abstract

The key intermediate of antihypertensive drugs trandolapril, (2S,3aR,7aS)-benzyl octahydro-1H-indole-2-car-boxylate, was synthesized by improvement of synthetic route and optimation of synthetic technology with satisfactory results (99% ee and 13.2% overall yield). The structure and absolute configuration of the product were characterized by NMR and HPLC analysis, which are completely consistent with the reported data of the literature. It was obvious that the current methodology provided an efficient pathway for the synthesis of trandolapril.

Key words： trandolapril; benzyl octahydro-1H-indole-2-carboxylate; synthesis

参考文献

[1] (a) Fang, Z.; Yang, Z.; Wei, P.; Chen, G.-G. Chin. Pharm. J. 2008, 48, 632 (in Chinese). (方正, 杨照, 韦萍, 陈国广, 中国药学杂志, 2008, 48, 632.) (b) Yang, Z.; Fang, Z.; Wang, Z.-X. Chem. Reag. 2007, 29, 281 (in Chinese). (杨照, 方正, 王志祥, 化学试剂, 2007, 29, 281.)
[2] (a) Urbach, H.; Henning, R.; Teetz, V. US 4933361, 1990[Chem. Abstr. 1984, 100, 34404]. (b) Cid, P.; Polabo, S. L. WO 05054194, 2005[Chem. Abstr. 2005, 143, 44076].
[3] (a) Henning, R.; Urbach, H. US 4691022, 1987[Chem. Abstr. 1985, 103, 71186]. (b) Li, J.-H.; Zhong, J.-F.; Shi, H.-L. Chin. J. Pharm. 2007, 38, 465 (in Chinese). (李建华, 钟静芬, 时惠麟, 中国医药工业杂志, 2007, 38, 465.)
[4] Henning, R.; Urbach, H. Tetrahedron Lett. 1983, 24, 5343.
[5] Urbach, H.; Henning, R.; Teetz, V. US 4933361, 1990[Chem. Abstr. 1984, 100, 34407].
[6] Brion, F.; Buendia, J.; Marie, C. US 4879392, 1989[Chem. Abstr. 1988, 109, 110255].
[7] (a) Zhao, L.; Shen, J.; Liu, D.; Liu, Y.; Zhang, W. Org. Biomol. Chem. 2012, 10, 2840. (b) Shen, J.; An, Q.; Liu, D.; Liu, Y.; Zhang, W. Chin. J. Chem. 2012, 30, 2681. (c) Shen, J.; Liu, D.; An, Q.; Liu, Y.; Zhang, W. Adv. Synth. Catal. 2012, 354, 3311.
[8] (a) Luca, L. D.; Giacomelli, G.; Masala, S.; Porcheddu, A. J. Org. Chem. 2003, 68, 4999. (b) Ryo, N.; Yu, I.; Takashi, M.; Junji, I. J. Org. Chem. 2006, 71, 8748. (c) Luca, L. D.; Giacomelli, G.; Porcheddu, A. Org. Lett. 2001, 3, 3041.
[9] Nyasse, B.; Grehn, L.; Ragnarsson, U. J. Chem. Soc., Chem. Commun. 1997, 1017.
[10] Thakur, V. V.; Sudalai, A. Tetrahedron Lett. 2003, 44, 989.
[11] Pattenden, L. C.; Wybrow, R. A. J.; Smith, S. A.; Harrity, J. P. A. Org. Lett. 2006, 8, 3089.
Options
文章导航

/

〈 〉